J. David Hansen

2014

In 2014, J. David Hansen earned a total compensation of $373.1K as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 44% decrease compared to previous year.

Compensation breakdown

Bonus$32,318
Salary$315,660
Other$25,142
Total$373,120

Hansen received $315.7K in salary, accounting for 85% of the total pay in 2014.

Hansen also received $32.3K in bonus and $25.1K in other compensation.

Rankings

In 2014, J. David Hansen's compensation ranked 11,179th out of 13,032 executives tracked by ExecPay. In other words, Hansen earned more than 14.2% of executives.

ClassificationRankingPercentile
All
11,179
out of 13,032
14th
Division
Manufacturing
4,280
out of 4,965
14th
Major group
Chemicals And Allied Products
1,479
out of 1,690
13th
Industry group
Drugs
1,193
out of 1,369
13th
Industry
Pharmaceutical Preparations
915
out of 1,042
12th
Source: SEC filing on May 27, 2016.

Hansen's colleagues

We found four more compensation records of executives who worked with J. David Hansen at MabVax Therapeutics Holdings in 2014.

2014

Michael Wick

MabVax Therapeutics Holdings

Chief Executive Officer

2014

Gregory Hanson

MabVax Therapeutics Holdings

Chief Financial Officer

2014

Wolfgang Scholz

MabVax Therapeutics Holdings

Vice President, Antibody Discovery

2014

Paul Maffuid

MabVax Therapeutics Holdings

Vice President, Pharmaceutical Development and Operations

You may also like